{"id":"https://openalex.org/W4387845926","doi":"https://doi.org/10.1007/s12072-023-10603-z","title":"Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinoma","display_name":"Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinoma","publication_year":2023,"publication_date":"2023-10-21","ids":{"openalex":"https://openalex.org/W4387845926","doi":"https://doi.org/10.1007/s12072-023-10603-z","pmid":"https://pubmed.ncbi.nlm.nih.gov/37864726","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11014819"},"language":"en","primary_location":{"id":"doi:10.1007/s12072-023-10603-z","doi":"https://doi.org/10.1007/s12072-023-10603-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12072-023-10603-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12072-023-10603-z.pdf","source":{"id":"https://openalex.org/S94180312","display_name":"Hepatology International","issn_l":"1936-0533","issn":["1936-0533","1936-0541"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology International","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s12072-023-10603-z.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102976701","display_name":"Hiroyuki Suzuki","orcid":"https://orcid.org/0000-0003-2383-5038","observed_orcids":["https://orcid.org/0000-0003-2383-5038"]},"institutions":[{"id":"https://openalex.org/I105296287","display_name":"Kurume University","ror":"https://ror.org/057xtrt18","country_code":"JP","type":"education","lineage":["https://openalex.org/I105296287"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Hiroyuki Suzuki","raw_affiliation_strings":["Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan. suzuki_hiroyuki@med.kurume-u.ac.jp","Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan. suzuki_hiroyuki@med.kurume-u.ac.jp","Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan","Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan"],"raw_orcid":"https://orcid.org/0000-0003-2383-5038","affiliations":[{"raw_affiliation_string":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan. suzuki_hiroyuki@med.kurume-u.ac.jp","institution_ids":["https://openalex.org/I105296287"]},{"raw_affiliation_string":"Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan. suzuki_hiroyuki@med.kurume-u.ac.jp","institution_ids":["https://openalex.org/I105296287"]},{"raw_affiliation_string":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan","institution_ids":["https://openalex.org/I105296287"]},{"raw_affiliation_string":"Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan","institution_ids":["https://openalex.org/I105296287"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084839932","display_name":"Hideki Iwamoto","orcid":"https://orcid.org/0000-0001-5688-1335","observed_orcids":["https://orcid.org/0000-0001-5688-1335"]},"institutions":[{"id":"https://openalex.org/I105296287","display_name":"Kurume University","ror":"https://ror.org/057xtrt18","country_code":"JP","type":"education","lineage":["https://openalex.org/I105296287"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Hideki Iwamoto","raw_affiliation_strings":["Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan. iwamoto_hideki@med.kurume-u.ac.jp","Iwamoto Internal Medicine Clinic, Kitakyushu, 802-0832, Japan. iwamoto_hideki@med.kurume-u.ac.jp","Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan. iwamoto_hideki@med.kurume-u.ac.jp","Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan","Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan"],"raw_orcid":"https://orcid.org/0000-0001-5688-1335","affiliations":[{"raw_affiliation_string":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan. iwamoto_hideki@med.kurume-u.ac.jp","institution_ids":["https://openalex.org/I105296287"]},{"raw_affiliation_string":"Iwamoto Internal Medicine Clinic, Kitakyushu, 802-0832, Japan. iwamoto_hideki@med.kurume-u.ac.jp","institution_ids":[]},{"raw_affiliation_string":"Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan. iwamoto_hideki@med.kurume-u.ac.jp","institution_ids":["https://openalex.org/I105296287"]},{"raw_affiliation_string":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan","institution_ids":["https://openalex.org/I105296287"]},{"raw_affiliation_string":"Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan","institution_ids":["https://openalex.org/I105296287"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102710463","display_name":"Toshimitsu Tanaka","orcid":"https://orcid.org/0000-0002-9309-2244","observed_orcids":["https://orcid.org/0000-0002-9309-2244"]},"institutions":[{"id":"https://openalex.org/I105296287","display_name":"Kurume University","ror":"https://ror.org/057xtrt18","country_code":"JP","type":"education","lineage":["https://openalex.org/I105296287"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshimitsu Tanaka","raw_affiliation_strings":["Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan","Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan","institution_ids":["https://openalex.org/I105296287"]},{"raw_affiliation_string":"Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan","institution_ids":["https://openalex.org/I105296287"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110645385","display_name":"Takahiko Sakaue","orcid":"https://orcid.org/0009-0003-1814-3456","observed_orcids":["https://orcid.org/0009-0003-1814-3456"]},"institutions":[{"id":"https://openalex.org/I105296287","display_name":"Kurume University","ror":"https://ror.org/057xtrt18","country_code":"JP","type":"education","lineage":["https://openalex.org/I105296287"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takahiko Sakaue","raw_affiliation_strings":["Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan","Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan","institution_ids":["https://openalex.org/I105296287"]},{"raw_affiliation_string":"Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan","institution_ids":["https://openalex.org/I105296287"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081166650","display_name":"Yasuko Imamura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105296287","display_name":"Kurume University","ror":"https://ror.org/057xtrt18","country_code":"JP","type":"education","lineage":["https://openalex.org/I105296287"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuko Imamura","raw_affiliation_strings":["Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan","institution_ids":["https://openalex.org/I105296287"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017194762","display_name":"Atsutaka Masuda","orcid":"https://orcid.org/0009-0000-3183-1200","observed_orcids":["https://orcid.org/0009-0000-3183-1200"]},"institutions":[{"id":"https://openalex.org/I105296287","display_name":"Kurume University","ror":"https://ror.org/057xtrt18","country_code":"JP","type":"education","lineage":["https://openalex.org/I105296287"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Atsutaka Masuda","raw_affiliation_strings":["Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan","Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan","institution_ids":["https://openalex.org/I105296287"]},{"raw_affiliation_string":"Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan","institution_ids":["https://openalex.org/I105296287"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060744842","display_name":"T\u00f5ru Nakamura","orcid":"https://orcid.org/0000-0002-9199-4551","observed_orcids":["https://orcid.org/0000-0002-9199-4551"]},"institutions":[{"id":"https://openalex.org/I105296287","display_name":"Kurume University","ror":"https://ror.org/057xtrt18","country_code":"JP","type":"education","lineage":["https://openalex.org/I105296287"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toru Nakamura","raw_affiliation_strings":["Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan","Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan","institution_ids":["https://openalex.org/I105296287"]},{"raw_affiliation_string":"Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan","institution_ids":["https://openalex.org/I105296287"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012513340","display_name":"Hironori Koga","orcid":"https://orcid.org/0000-0001-5814-9543","observed_orcids":["https://orcid.org/0000-0001-5814-9543"]},"institutions":[{"id":"https://openalex.org/I105296287","display_name":"Kurume University","ror":"https://ror.org/057xtrt18","country_code":"JP","type":"education","lineage":["https://openalex.org/I105296287"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hironori Koga","raw_affiliation_strings":["Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan","Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan","institution_ids":["https://openalex.org/I105296287"]},{"raw_affiliation_string":"Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, 830-0011, Japan","institution_ids":["https://openalex.org/I105296287"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007607351","display_name":"Yujin Hoshida","orcid":"https://orcid.org/0000-0001-9430-1426","observed_orcids":["https://orcid.org/0000-0001-9430-1426"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yujin Hoshida","raw_affiliation_strings":["Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101842545","display_name":"Takumi Kawaguchi","orcid":"https://orcid.org/0000-0002-7064-4325","observed_orcids":["https://orcid.org/0000-0002-7064-4325"]},"institutions":[{"id":"https://openalex.org/I105296287","display_name":"Kurume University","ror":"https://ror.org/057xtrt18","country_code":"JP","type":"education","lineage":["https://openalex.org/I105296287"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takumi Kawaguchi","raw_affiliation_strings":["Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan","institution_ids":["https://openalex.org/I105296287"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5084839932","https://openalex.org/A5102976701"],"corresponding_institution_ids":["https://openalex.org/I105296287"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":{"value":4590,"currency":"USD","value_usd":4590},"fwci":3.3457,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.93667507,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"18","issue":"2","first_page":"610","last_page":"622"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.7515000104904175,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.7515000104904175,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.21629999577999115,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.01889999955892563,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.7900000214576721},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.8050000071525574},{"id":"https://openalex.org/keywords/azd4547","display_name":"AZD4547","score":0.9449999928474426},{"id":"https://openalex.org/keywords/lenvatinib","display_name":"lenvatinib","score":0.9890000224113464},{"id":"https://openalex.org/keywords/cabozantinib","display_name":"cabozantinib","score":0.9890000224113464},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.921999990940094},{"id":"https://openalex.org/keywords/regorafenib","display_name":"regorafenib","score":0.9950000047683716},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7260000109672546},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.8809999823570251},{"id":"https://openalex.org/keywords/vegfr-2-inhibition","display_name":"VEGFR-2 inhibition","score":0.6269999742507935},{"id":"https://openalex.org/keywords/lipid-metabolism","display_name":"lipid metabolism","score":0.6110000014305115},{"id":"https://openalex.org/keywords/innate-immune-activation","display_name":"innate immune activation","score":0.6980000138282776},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.6840000152587891},{"id":"https://openalex.org/keywords/foxp3","display_name":"Foxp3","score":0.7369999885559082}],"concepts":[{"id":"https://openalex.org/C2776264508","wikidata":"https://www.wikidata.org/wiki/Q6523413","display_name":"Lenvatinib","level":4,"score":0.9798104763031006},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7010499238967896},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.6327396631240845},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6215651035308838},{"id":"https://openalex.org/C2780380082","wikidata":"https://www.wikidata.org/wiki/Q12646460","display_name":"Granzyme B","level":4,"score":0.5397914052009583},{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.5382516384124756},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.476928174495697},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4661461412906647},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.4600204825401306},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.4548434019088745},{"id":"https://openalex.org/C2779727006","wikidata":"https://www.wikidata.org/wiki/Q426188","display_name":"FOXP3","level":3,"score":0.4506419897079468},{"id":"https://openalex.org/C183193105","wikidata":"https://www.wikidata.org/wiki/Q425068","display_name":"Granzyme","level":5,"score":0.44694775342941284},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3948192298412323},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3635685443878174},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3635196089744568},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31015241146087646},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.30399706959724426},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.22139635682106018},{"id":"https://openalex.org/C2776062744","wikidata":"https://www.wikidata.org/wiki/Q21103279","display_name":"Perforin","level":4,"score":0.1403370499610901}],"mesh":[{"descriptor_ui":"D000813","descriptor_name":"Anilides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005346","descriptor_name":"Fibroblast Growth Factors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005346","descriptor_name":"Fibroblast Growth Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051858","descriptor_name":"Forkhead Transcription Factors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051858","descriptor_name":"Forkhead Transcription Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D053804","descriptor_name":"Granzymes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D053804","descriptor_name":"Granzymes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s12072-023-10603-z","doi":"https://doi.org/10.1007/s12072-023-10603-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12072-023-10603-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12072-023-10603-z.pdf","source":{"id":"https://openalex.org/S94180312","display_name":"Hepatology International","issn_l":"1936-0533","issn":["1936-0533","1936-0541"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology International","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11014819","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11014819","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatol Int","raw_type":"Text"},{"id":"pmid:37864726","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37864726","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology international","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s12072-023-10603-z","doi":"https://doi.org/10.1007/s12072-023-10603-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12072-023-10603-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12072-023-10603-z.pdf","source":{"id":"https://openalex.org/S94180312","display_name":"Hepatology International","issn_l":"1936-0533","issn":["1936-0533","1936-0541"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology International","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5709731452","display_name":"Epigallocatechin gallate for prevention of lethal cirrhosis complications","funder_award_id":"R01CA282178","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7392301715","display_name":"Reverse-engineering precision liver cancer chemoprevention","funder_award_id":"R01CA233794","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000876715","display_name":"Trial of Statins for Chemoprevention in Hepatocellular Carcinoma","funder_award_id":"R01CA255621","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320309807","display_name":"Takeda Science Foundation","ror":"https://ror.org/02y123g31"},{"id":"https://openalex.org/F4320318066","display_name":"Shinnihon Foundation of Advanced Medical Treatment Research","ror":"https://ror.org/040z3gh14"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387845926.pdf","grobid_xml":"https://content.openalex.org/works/W4387845926.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W1976651544","https://openalex.org/W1980457090","https://openalex.org/W2073454150","https://openalex.org/W2122683221","https://openalex.org/W2125307286","https://openalex.org/W2783439615","https://openalex.org/W2917680953","https://openalex.org/W2963572064","https://openalex.org/W3017272765","https://openalex.org/W3022705128","https://openalex.org/W3048967465","https://openalex.org/W3118950316","https://openalex.org/W3121497974","https://openalex.org/W3128646645","https://openalex.org/W3138484572","https://openalex.org/W3152534107","https://openalex.org/W3165017392","https://openalex.org/W3168166128","https://openalex.org/W3170378498","https://openalex.org/W3185231871","https://openalex.org/W3203101658","https://openalex.org/W3207086895","https://openalex.org/W3211335624","https://openalex.org/W3212668399","https://openalex.org/W3215011445","https://openalex.org/W4220851453","https://openalex.org/W4224319588","https://openalex.org/W4225101426","https://openalex.org/W4292553490","https://openalex.org/W4294191660","https://openalex.org/W4305014055","https://openalex.org/W4327571871","https://openalex.org/W4327918028","https://openalex.org/W4360951491","https://openalex.org/W4362633521","https://openalex.org/W4365483656","https://openalex.org/W4380153036","https://openalex.org/W4380422055","https://openalex.org/W4384820874","https://openalex.org/W4387521898","https://openalex.org/W4388694835"],"related_works":["https://openalex.org/W3008414152","https://openalex.org/W7160645290","https://openalex.org/W2901757914","https://openalex.org/W4386813575","https://openalex.org/W3175577386","https://openalex.org/W3155194275","https://openalex.org/W7133307858","https://openalex.org/W4292553490","https://openalex.org/W4401346087","https://openalex.org/W3165017392"],"abstract_inverted_index":{"BACKGROUND":[0],"&":[1],"AIMS:":[2],"Combination":[3],"immunotherapy":[4],"refers":[5],"to":[6,32,39,55,282],"the":[7,24,57,62,114,148,156,177,191,200,213,267,295],"use":[8,297],"of":[9,26,59,151,159,168,185,215,298],"immune":[10,64,70,269,285],"checkpoint":[11],"inhibitors":[12],"(ICI)":[13],"and":[14,78,80,89,98,135,143,187,206,210,219,235,271,273],"molecular-targeted":[15],"agents":[16],"(MTA),":[17],"which":[18,275],"have":[19],"recently":[20],"been":[21],"approved":[22],"for":[23,108,124,170],"treatment":[25,45],"advanced":[27],"hepatocellular":[28],"carcinoma":[29],"(HCC).":[30],"Owing":[31],"its":[33],"relatively":[34],"low":[35],"antitumor":[36],"effect":[37],"(up":[38],"30%),":[40],"sequential":[41],"therapy":[42],"following":[43],"ICIs":[44],"is":[46],"required":[47],"in":[48,113,190,195,202,245,254],"patients":[49],"with":[50,83,165,249],"HCC.":[51],"This":[52],"study":[53],"aimed":[54],"determine":[56],"impact":[58],"MTAs":[60,84,118],"on":[61],"tumor":[63],"microenvironment":[65],"(TIME).":[66],"METHODS:":[67],"We":[68,137],"established":[69],"syngeneic":[71],"orthotopic":[72],"HCC":[73,161,256],"mouse":[74],"models":[75,247],"using":[76,121,141,173],"Hep-55.1C":[77],"Hep-53.4,":[79],"treated":[81,164],"them":[82],"(lenvatinib,":[85],"sorafenib,":[86],"regorafenib,":[87],"cabozantinib,":[88],"DC101":[90],"as":[91,100],"anti-vascular":[92],"endothelial":[93],"growth":[94,103],"factor":[95,104],"receptor-2":[96],"antibodies,":[97],"AZD4547":[99,211],"a":[101,283],"fibroblast":[102],"receptor":[105],"(FGFR)-1/2/3/4":[106],"inhibitor)":[107],"2":[109],"weeks.":[110],"Subsequently,":[111],"alterations":[112],"TIME":[115,192,281],"caused":[116],"by":[117,233,242,252,287],"were":[119,231],"evaluated":[120],"immunohistochemistry":[122],"(antibodies":[123],"CD3,":[125],"CD8,":[126,216],"Foxp3,":[127],"Granzyme":[128,204,217],"B,":[129,205,218],"Arginase-1,":[130],"NK1.1,":[131],"F4/80,":[132],"CD11c,":[133],"PD-1,":[134],"PD-L1).":[136],"conducted":[138],"RNA-seq":[139,174],"analysis":[140,225],"lenvatinib-":[142],"AZD4547-treated":[144],"tumors.":[145],"To":[146],"confirm":[147],"clinical":[149],"relevance":[150],"these":[152],"findings,":[153],"we":[154,262],"analyzed":[155],"transcriptome":[157],"data":[158,175],"human":[160,255],"cells":[162,189],"(MHCC-97H)":[163],"various":[166],"concentrations":[167],"lenvatinib":[169,234,253,272],"24":[171],"h":[172],"from":[176],"Gene":[178,222],"Expression":[179],"Omnibus":[180],"database.":[181],"RESULTS:":[182],"The":[183],"number":[184,214],"Foxp3-":[186],"F4/80-positive":[188],"was":[193],"decreased":[194],"many":[196],"MTAs.":[197],"Cabozantinib":[198],"increased":[199,212],"numbers":[201],"NK1.1-,":[203],"CD11c-positive":[207],"cells.":[208,221,257],"Lenvatinib":[209],"PD-L1-positive":[220],"ontology":[223],"enrichment":[224],"revealed":[226],"that":[227,264],"lipid":[228,289],"metabolism-related":[229,290],"genes":[230,240],"downregulated":[232,241,251],"AZD4547.":[236],"In":[237,259],"total,":[238],"161":[239],"FGFR":[243,278],"inhibition":[244],"rodent":[246],"overlapped":[248],"those":[250],"CONCLUSIONS:":[258],"this":[260],"study,":[261],"showed":[263],"cabozantinib":[265],"activated":[266],"innate":[268],"system,":[270],"AZD4547,":[274],"commonly":[276],"inhibit":[277],"signaling,":[279],"altered":[280],"hot":[284],"state":[286],"downregulating":[288],"genes.":[291],"These":[292],"findings":[293],"support":[294],"therapeutic":[296],"combination":[299],"immunotherapies.":[300]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-10-22T00:00:00"}